---
document_datetime: 2023-09-21 17:02:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ibandronic-acid-sandoz-epar-all-authorised-presentations_en.pdf
document_name: ibandronic-acid-sandoz-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9408643
conversion_datetime: 2025-12-19 03:22:16.160203
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Name                   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                | Package size   |
|-----------------|------------------------|------------|-----------------------|---------------------------|--------------------------|----------------|
| EU/1/11/685/001 | Ibandronic acid Sandoz | 50 mg      | Film-coated tablet    | Oral use                  | blister (PA/ALL/PVC/alu) | 3 tablets      |
| EU/1/11/685/002 | Ibandronic acid Sandoz | 50 mg      | Film-coated tablet    | Oral use                  | blister (PA/ALL/PVC/alu) | 6 tablets      |
| EU/1/11/685/003 | Ibandronic acid Sandoz | 50 mg      | Film-coated tablet    | Oral use                  | blister (PA/ALL/PVC/alu) | 9 tablets      |
| EU/1/11/685/004 | Ibandronic acid Sandoz | 50 mg      | Film-coated tablet    | Oral use                  | blister (PA/ALL/PVC/alu) | 28 tablets     |
| EU/1/11/685/005 | Ibandronic acid Sandoz | 50 mg      | Film-coated tablet    | Oral use                  | blister (PA/ALL/PVC/alu) | 84 tablets     |